Study Confirms Surfacide UV-C Kills SARS-CoV-2

A recent peer-reviewed study in the Journal of Clinical Anesthesia* found the Surfacide Helios® System UV-C technology is nearly 95% effective in preventing SARS CoV-2 in patient environments. This is the first clinical study that evaluates the use of UV-C in...

AORN Recommends Nasal Decolonization with PVP-I

The Association of periOperative Registered Nurses (AORN) has announced its annual updated recommendations on the "Guideline for Preoperative Skin Antisepsis," to assist health care professionals in navigating risk-based decisions for developing preoperative...

New AAAHC Quality Roadmap Probes Data, Highlights Surveyor Insights

On June 16, AAAHC released its 2021 Quality Roadmap, a comprehensive analysis of data from more than 1,120 accreditation surveys conducted in 2020.

RSIP Vision Reveals New Module

RSIP Vision has announced its new surgical workflow analysis technology, which can intelligently identify each separate stage of a surgical procedure and label them accordingly throughout the duration of the procedure.

Encompass Group Launches Airisana Therapeutic Support Surface at WOCNEXT 2019

Encompass Group, LLC introduces the transformative Airisana™ Therapeutic Support Surface, a new approach to pressure management therapy and microclimate.

Encompass Group LLC premiered its new Airisana Therapeutic Support Surface at the WOCNEXT 2019 Conference in Nashville, Tennessee. Airisana is a unique, never-before-seen approach to pressure management therapy and microclimate. By combining all of the best practices devised to reduce healthcare-acquired pressure injuries into one surface and control unit, it replaces up to five other surface types.

“The Airisana surface was developed because, even with the multitude of surfaces currently available, healthcare-acquired pressure injury (HAPI) rates have not only stopped declining, they’ve actually risen in the last few years,” said Michelle Daniels, Airisana managing director for product development. “In the 2017 AHRQ measure of different hospital-acquired conditions (HACs), such as infections, falls, VTEs, drug errors and pressure injuries, only the rate of pressure injuries had risen – by 6% – since 2014, whereas the average reduction of all HACs was at 13%. We needed to do something to address this pressure-injury epidemic, which affects almost 19% of all hospital inpatients today.”

The Airisana surface offers a newly developed algorithm that combines multiple pressure therapies, such as alternating pressure, immersion, envelopment, and pressure redistribution, in a random sequence, to reduce patients’ acclimatization to the therapy provided by the surface. And uniquely, Airisana provides multiple therapy modes at the same time. Pressure therapy modes and turn assist can be performed in concert. Airisana’s innovative bladder design can incorporate pressure redistribution, alternating pressure and envelopment therapies with a transformative inflation sequence. All at the same time; all in one surface.

As a low-air-loss surface, Airisana supports reduction for moisture-associated dermatitis and accelerated skin breakdown, by applying a targeted airflow to the highest patient pressure points on the surface, providing air therapy where it is needed the most. Other low-air-loss surfaces apply an even application of air across the entire surface regardless of where it is needed, which can over-dry the skin and potentially cause new conditions.

Because of its ability to combine several best practices into one surface, the Airisana surface is designed to support multiple care disciplines (wound care, respiratory care, physical therapy, etc.), rather than to benefit just one discipline while potentially presenting challenges for others. With its stable base and firm perimeter support, the Airisana Surface can be used bedside for many respiratory, physical and other therapy care situations.

Its intuitive, soft-touch user control unit simplifies patient set up and puts control back into the hands of clinicians. Airisana is designed to help hospitals manage the risk of extended patient stays, lessen the risk of staff injuring themselves when repositioning patients, and help hospitals save money through improved clinical efficiency.

“We designed Airisana in consultation with medical engineers, biologists, clinicians, and WOC nurse professionals to improve several issues associated with current therapies and surfaces,” Daniels went on to say. “Such as improving clinical efficiency and reducing costs; shortening the time-released-to-care and time-to-mobility; reducing pressure- and moisture-associated skin deterioration; reducing staff injuries from repositioning patients; easing egress and ingress; and reducing acclimatization of the patient to the surface. Our goal with Airisana is to get healthcare-acquired pressure injury rates pointed back in the right direction: Down.”

Encompass also rolled out a new website to support the Airisana surface launch, which includes insights into Airisana’s inspiration and development along with a calculator to assist hospitals and health care systems in measuring the economic impact of pressure injuries. Full information is available at

Encompass is also launching a facility evaluation program. Interested facilities can request to participate at



Submit a Comment

Your email address will not be published. Required fields are marked *